fluoroquinolones

FDA ADVISES RESTRICTING FLUOROQUINOLONE ANTIBIOTIC USE FOR CERTAIN INFECTIONS; WARNS ABOUT DISABLING SIDE EFFECTS

 

East County News Service

May 13, 2016 (Washington D.C.) - The U.S. Food and Drug Administration is advising that the serious side effects associated with fluoroquinolone antibacterial drugs generally outweigh the benefits for patients with sinusitis, bronchitis, and uncomplicated urinary tract infections who have other treatment options. For patients with these conditions, fluoroquinolone should be reserved for those who do not have alternative treatment options.


Error message

Support community news in the public interest! As nonprofit news, we rely on donations from the public to fund our reporting -- not special interests. Please donate to sustain East County Magazine's local reporting and/or wildfire alerts at https://www.eastcountymedia.org/donate to help us keep people safe and informed across our region.